RESUMEN
Relationship between rumen fermentation parameters, blood biochemical profiles and milk production traits in different yielding dairy cows during early lactation was investigated. Twelve dairy cows were divided into two groups based on their milk yield, that is low-yield (LY) and high-yield (HY) groups. Rumen fluid and blood were collected at 3 weeks prepartum and 4, 8 and 12 weeks postpartum. Results showed that proportions of acetate, propionate to total short chain fatty acids and acetate : propionate ratio were changed (P < 0.05) in both groups during the peripartum period, whereas butyrate and acetate : butyrate ratio were only altered in the HY group. Blood cholesterol, beta-hydroxybutyric acid (BHBA) and glutamic oxaloacetic transaminase in the HY group were higher (P < 0.01) than those in the LY group. Principal component analysis revealed that milk yield and milk compositions were differently clustered between groups. These parameters showed similar direction with dry matter intake in the HY group and adverse direction in the LY group. Linear regression analysis indicated that butyrate was positively correlated with BHBA (P < 0.05) in the HY group. This study suggests that cows in the HY group seem to accommodate appropriately to negative energy balance in early lactation through rumen fermentation.
Asunto(s)
Alimentación Animal , Bovinos/metabolismo , Bovinos/fisiología , Dieta/veterinaria , Fermentación/fisiología , Lactancia/fisiología , Rumen/metabolismo , Rumen/fisiología , Ácido 3-Hidroxibutírico/sangre , Acetatos/sangre , Acetatos/metabolismo , Animales , Aspartato Aminotransferasas/sangre , Colesterol/sangre , Metabolismo Energético , Ácidos Grasos Volátiles/sangre , Ácidos Grasos Volátiles/metabolismo , Femenino , Leche/química , Periodo Periparto , Propionatos/sangre , Propionatos/metabolismo , Tiocarbamatos/sangre , Tiocarbamatos/metabolismoRESUMEN
Disulfiram (DSF), a treatment for alcohol use disorders, has shown some clinical effectiveness in treating addiction to cocaine, nicotine, and pathological gambling. The mechanism of action of DSF for treating these addictions is unclear but it is unlikely to involve the inhibition of liver aldehyde dehydrogenase (ALDH2). DSF is a pro-drug and forms a number of metabolites, one of which is N-acetyl-S-(N,N-diethylcarbamoyl) cysteine (DETC-NAC). Here we describe a LCMS/MS method on a QQQ type instrument to quantify DETC-NAC in plasma and intracellular fluid from mammalian brain. An internal standard, the N,N-di-isopropylcarbamoyl homolog (MIM: 291>128) is easily separable from DETC-NAC (MIM: 263>100) on C18 RP media with a methanol gradient. The method's linear range is 0.5-500 nM from plasma and dialysate salt solution with all precisions better than 10% RSD. DETC-NAC and internal standards were recovered at better than 95% from all matrices, perchloric acid precipitation (plasma) or formic acid addition (salt) and is stable in plasma or salt at low pH for up to 24 h. Stability is observed through three freeze-thaw cycles per day for 7 days. No HPLC peak area matrix effect was greater than 10%. A human plasma sample from a prior analysis for S-(N,N-diethylcarbamoyl) glutathione (CARB) was found to have DETC NAC as well. In other human plasma samples from 62.5 mg/d and 250 mg/d dosing, CARB concentration peaks at 0.3 and 4 nM at 3 h followed by DETC-NAC peaks of 11 and 70 nM 2 h later. Employing microdialysis sampling, DETC-NAC levels in the nucleus accumbens (NAc), medial prefrontal cortex (mPFC), and plasma of rats treated with DSF reached 1.1, 2.5 and 80 nM at 6h. The correlation between the appearance and long duration of DETC-NAC concentration in rat brain and the persistence of DSF-induced changes in neurotransmitters observed by Faiman et al. (Neuropharmacology, 2013, 75C, 95-105) is discussed.
Asunto(s)
Acetilcisteína/análogos & derivados , Disulfiram/sangre , Disulfiram/metabolismo , Núcleo Accumbens/metabolismo , Corteza Prefrontal/metabolismo , Tiocarbamatos/metabolismo , Acetilcisteína/sangre , Acetilcisteína/metabolismo , Animales , Femenino , Humanos , Masculino , Microdiálisis/métodos , Profármacos/metabolismo , Ratas , Ratas Sprague-Dawley , Tiocarbamatos/sangreRESUMEN
OBJECTIVE: To establish a method for determining 2, 4-D butylate in serum by gas chromatography (GC)and to provide a basis for the diagnosis and treatment of clinical poisoning. METHODS: Serum 2, 4-D butylate level was determined by the following steps: mixing serum (0.5 ml)with trichloromethane (2.0 ml), adequately shaking for extraction, standing for 5 min, centrifuging at 4 000 rpm for 10 min, blow-drying the trichloromethane layer with nitrogen, adding ethanol (50 µl)to a certain volume, adding the sample (1.0 µl), and performing GC with a hydrogen flame ionization detector. RESULTS: Serum 2, 4-D butylate level showed a linear relationship within 5â¼40 µg/ml, with a regression equation of y = 1 831.6.4x-899.4 (r = 0.999 2); the minimum detectable concentration was 1.0 µg/ml. The recovery rate was 88.7%â¼103.0% (relative standard deviation (RSD) 3.8%â¼5.0%). The intra-day RSD and inter-day RSD were 3.87-4.92% and 3.33%â¼5.34%, respectively. CONCLUSION: This determination method is simple, efficient, and accurate and provides a good means for rapid diagnosis and treatment of 2, 4-D butylate poisoning.
Asunto(s)
Cromatografía de Gases/métodos , Suero/química , Tiocarbamatos/sangre , HumanosRESUMEN
A capillary liquid chromatography with UV detection (CLC-UV) system has been developed for determining platinum-based antitumor drugs (e.g., cisplatin, carboplatin, and nedaplatin) in plasma based on the pre-column derivatization of platinum with N,N-diethyl dithiocarbamate (DDTC). The chelated platinum separation was carried out on a capillary column (Inertsil ODS-3, 150 mm × 0.3 mm i.d., 3 µm) using an acetonitrile-water mixture (8:2, v/v) as a mobile phase that flowed at 5.0 µL/min. Detection was carried out by absorbance at 254 nm. Chromatographic peak height was found to be linearly related to the spiked concentration of nedaplatin in the blank control plasma from 5.0 ng/mL to 15 µg/mL (r(2)>0.998). The repeatability (n=5) of the chromatographic peak height for 2.5 µg/mL nedaplatin was 2.6% relative standard deviation (R.S.D.). The CLC-UV system, which required only 20 µL of plasma sample, was applied to the determination of total and free form platinum-based antitumor drugs in plasma after injection into rats. The recovery rates (n=5) of total and free form nedaplatin in plasma were 98% and 99%, respectively, and these repeatability were 2.4% R.S.D. and 3.1% R.S.D., respectively. In addition, the recovery rates (n=5) of total and free form carboplatin in plasma were 99% and 99%, respectively, and these repeatability were 2.9% R.S.D. and 0.24% R.S.D., respectively. The concentration-time profiles of total and free form nedaplatin in rat plasma were monitored to determine the pharmacokinetic parameters.
Asunto(s)
Antineoplásicos/sangre , Cromatografía Líquida de Alta Presión , Platino (Metal)/química , Tiocarbamatos/sangre , Animales , Carboplatino/sangre , Cisplatino/sangre , Inyecciones Intraperitoneales , Masculino , Compuestos Organoplatinos/sangre , Ratas , Ratas Wistar , Espectrofotometría UltravioletaRESUMEN
Disulfiram has been used extensively for alcohol abuse and may have a role in treatment for cocaine addiction. Recent data suggest that disulfiram may also reactivate latent HIV in reservoirs. Disulfiram has complex pharmacokinetics with rapid metabolism to active metabolites, including S-methyl-N,N-diethylthiocarbamate (DET-Me) which is formed from cytochrome P450 (CYP450). Assessing disulfiram in HIV-infected individuals with a CYP450 inducing drug (e.g., efavirenz) or a CYP450 inhibiting drug (e.g., HIV-1 protease inhibitors) requires an assay that can measure a metabolite that is formed directly via CYP450 oxidation. Therefore, an assay to measure concentrations of DET-Me in human plasma was validated. DET-Me and the internal standard, S-ethyldipropylthiocarbamate (EPTC) were separated by isocratic ultra performance liquid chromatography using a Waters Acquity HSS T3 column (2.1 mm × 100 mm, 1.8 µm) and detection via electrospray coupled to a triple quadrupole mass spectrometer. Multiple reaction monitoring in positive mode was used with DET-Me at 148/100 and the internal standard at 190/128 with a linear range of 0.500-50.0 ng/mL with a 5 min run time. Human plasma (500 µL) was extracted using a solid phase procedure. The interassay variation ranged from 1.86 to 7.74% while the intra assay variation ranged from 3.38 to 5.94% over three days. Representative results are provided from samples collected from subjects receiving daily doses of disulfiram 62.5mg or 250 mg.
Asunto(s)
Cromatografía de Fase Inversa/métodos , Disulfiram/metabolismo , Espectrometría de Masas/métodos , Tiocarbamatos/sangre , Cromatografía Líquida de Alta Presión/métodos , Disulfiram/sangre , Disulfiram/farmacocinética , Estabilidad de Medicamentos , Humanos , Reproducibilidad de los Resultados , Tiocarbamatos/metabolismo , Tiocarbamatos/farmacocinéticaRESUMEN
Molinate has been widely used as a pre-emergent herbicide in the rice fields of California's Central Valley. In rat studies, the metabolite molinate sulfoxide is suspected of causing testicular toxicity after exposure to molinate. The sulfoxide is generated in the liver and can circulate in the blood, eventually reaching the testis. Man qualitatively produces the same molinate metabolites as the rat. To extrapolate the reproductive risk to man, the present study outlines the development of a preliminary PBPK (physiologically-based pharmacokinetic) model, validation in the rat and extrapolation to man. The preliminary seven-compartment PBPK model for molinate was constructed for the adult, male Sprague-Dawley rat that employed both flow-limited (blood, kidney, liver, rapid-perfused tissues and slowly perfused tissues) and diffusion-limited (fat) rate equations. The systemic circulation connects the various compartments. The simulations predict the molinate blood concentrations of the rat blood and testes compartment favorably with the profiles obtained from 10 and 100mg/kg po or 1.5 and 15mg/kg iv doses. Human physiological parameters were substituted into the oral dosed model and the simulations closely predicted the molinate blood concentration obtained from 5.06mg oral dose. A sensitivity analysis determined for an oral dose that peak blood molinate concentrations were most responsive to the blood flows to kidney and fat compartments while testicular molinate sulfoxide concentrations depended on molinate sulfoxide partition coefficients for the testes compartment and the K(m) for glutathione conjugation of molinate sulfoxide in the liver compartment.
Asunto(s)
Azepinas/farmacocinética , Herbicidas/farmacocinética , Modelos Biológicos , Fenómenos Fisiológicos , Sulfóxidos/farmacocinética , Tiocarbamatos/farmacocinética , Administración Oral , Animales , Azepinas/sangre , Azepinas/toxicidad , Relación Dosis-Respuesta a Droga , Herbicidas/sangre , Herbicidas/toxicidad , Humanos , Inyecciones Intravenosas , Riñón/metabolismo , Riñón/fisiología , Hígado/metabolismo , Hígado/fisiología , Masculino , Estructura Molecular , Valor Predictivo de las Pruebas , Ratas , Ratas Sprague-Dawley , Especificidad de la Especie , Sulfóxidos/sangre , Sulfóxidos/toxicidad , Testículo/efectos de los fármacos , Testículo/metabolismo , Testículo/fisiología , Tiocarbamatos/sangre , Tiocarbamatos/toxicidad , Distribución TisularRESUMEN
Antileprosy activity of dialkyldithiocarbamate derivatives was studied in experiments on mice infected with M. leprae into paw pads. We found that 2-diethyldithiocarbamoyl-3-cyano-5-nitropyridine is the most promising antileprosy agent; it effectively suppresses multiplication of M. leprae and is well tolerated under conditions of chronic animal experiment.
Asunto(s)
Leprostáticos/uso terapéutico , Lepra/tratamiento farmacológico , Tiocarbamatos/uso terapéutico , Animales , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Leprostáticos/sangre , Lepra/sangre , Lepra/mortalidad , Lepra/veterinaria , Masculino , Ratones , Ratones Endogámicos CBA , Viabilidad Microbiana/efectos de los fármacos , Mycobacterium leprae/efectos de los fármacos , Mycobacterium leprae/fisiología , Tiocarbamatos/sangre , Tiocarbamatos/química , Resultado del TratamientoRESUMEN
The ciprofloxacin dithiocarbamate (CPFXDTC) was synthesized and radiolabeled with [(99m)TcN](2+) intermediate to form the (99m)TcN-CPFXDTC complex in high yield (>95%). No decomposition of the complex at room temperature was observed over a period of 6 h. Its partition coefficient indicated that it was a good lipophilic complex. The bacterial binding assay studies showed (99m)TcN-CPFXDTC had a better binding affinity as compared with (99m)Tc-ciprofloxacin. Biodistribution results in induced infection mice showed (99m)TcN-CPFXDTC had higher uptake at the sites of infection and better abscess/blood ratio than that of (99m)Tc-ciprofloxacin, suggesting (99m)TcN-CPFXDTC would be a novel potential infection imaging agent.
Asunto(s)
Ciprofloxacina , Compuestos de Organotecnecio , Radiofármacos , Tiocarbamatos/síntesis química , Animales , Ciprofloxacina/análogos & derivados , Ciprofloxacina/sangre , Ciprofloxacina/síntesis química , Ciprofloxacina/farmacocinética , Diagnóstico por Imagen , Masculino , Ratones , Estructura Molecular , Compuestos de Organotecnecio/sangre , Compuestos de Organotecnecio/síntesis química , Compuestos de Organotecnecio/farmacocinética , Tiocarbamatos/sangre , Tiocarbamatos/farmacocinética , Distribución Tisular , Recuento Corporal TotalRESUMEN
Differences in the toxicities observed for dithiocarbamates have been proposed to result from the influence of nitrogen substitution, oxidation state, and route of exposure. To better characterize the fate of dithiocarbmates in vivoas a function of structure and route of exposure, rats were administered equimolar doses of carbon disulfide (CS2), N-methyldithiocarbamate, pyrrolidine dithiocarbamate, N,N-diethyldithiocarbamate, or disulfiram daily for five days, either po or ip, and sequential blood samples obtained. Protein dithiocarbamates formed by the in vivo release of CS2, parent dithiocarbamate, and protein-bound mixed disulfides were assessed in plasma and hemolysate by measuring toluene trithiocarbonate generated upon treatment with toluene-3, 4-dithiol (TdT). To aid in determining the bioavailability of CS2 from the administered dithiocarbamates, the urinary CS2 metabolites, 2-thiothiazolidine-4-carboxylic acid (TTCA) and 2-thiothiazolidin-4-ylcarbonylglycine (TTCG), were also determined. The levels of TdT-reactive moieties detected depended upon both the compound administered and the route of exposure. Parent dithiocarbamates, with the exception of disulfiram, were eliminated from blood within 24 h; but protein associated TdT-reactive moieties persisted and accumulated with repeated exposure, regardless of the route of exposure. N-Methyldithiocarbamate demonstrated the greatest potential to produce intracellular globin modifications, presumably through its unique ability to generate a methylisothiocyanate metabolite. Urinary excretion of TTCA and TTCG was more sensitive than TdT analysis for detecting dithiocarbamate exposure, but TdT analysis appeared to be a better indicator of in vivo release of CS2 by dithiocarbamates than were urinary CS2 metabolites. These data suggest that CS2 is a more important metabolite, following oral exposure, than are other routes of exposure, e.g., inhalation or dermal. In addition, data also suggest that acid stability, nitrogen substitution, and route of exposure are important factors governing the toxicity observed for a particular dithiocarbamate.
Asunto(s)
Disulfuro de Carbono/metabolismo , Tiocarbamatos/química , Tolueno , Tolueno/análogos & derivados , Administración Oral , Animales , Cromatografía Líquida de Alta Presión , Inyecciones Intraperitoneales , Masculino , Proteínas/metabolismo , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad , Tiocarbamatos/sangre , Tiocarbamatos/orina , Distribución Tisular , Tolueno/sangre , Tolueno/metabolismo , Tolueno/orinaRESUMEN
BACKGROUND: Humans are exposed to substantial quantities of isothiocyanates and glucosinolates from vegetables. Since dietary isothiocyanates are widely regarded as potentially important chemoprotectors against cancer, reliable methods for measuring the plasma and tissue pharmacokinetics of isothiocyanates and their dithiocarbamate metabolites are essential for defining dosing regimens. METHODS: Isothiocyanates (ITC) and dithiocarbamates (DTC) react quantitatively with 1,2-benzenedithiol to produce 1,3-benzodithiole-2-thione that can be quantified spectroscopically. Although this cyclocondensation reaction has been highly useful for analyzing plant material and urine samples, the determination of DTC/ITC (the total quantity of DTC and ITC components in a sample that react in the cyclocondensation reaction) in blood and tissues has been hampered by their low levels and the high concentrations of proteins that interfere with the cyclocondensation reaction. The protein content of blood and tissues was reduced by the precipitation with polyethylene glycol (PEG) or ultrafiltration, and the sensitivity of the method was increased substantially by the solid phase extraction of the cyclocondensation product. RESULTS: Pharmacokinetic measurements were made in four human volunteers who received single doses of about 200 micromol of broccoli sprout isothiocyanates (largely sulforaphane, with lesser amounts of iberin and erucin). Isothiocyanates were absorbed rapidly, reached peak concentrations of 0.943-2.27 micromol/l in plasma, serum and erythrocytes at 1 h after feeding and declined with first-order kinetics (half-life of 1.77+/-0.13 h). The cumulative excretion at 8 h was 58.3+/-2.8% of the dose. Clearance was 369+/-53 ml/min, indicating active renal tubular secretion. CONCLUSION: A sensitive and specific method for quantifying DTC levels in human plasma, serum, and erythrocytes has been devised. Determinations of ITC/DTC levels are important because: (i) dietary isothiocyanates are of potential value in reducing the risk of cancer, and (ii) humans are extensively exposed to DTC as fungicides, insecticides, pesticides and rubber vulcanization accelerators.
Asunto(s)
Eritrocitos/química , Plasma/química , Tiocarbamatos/farmacocinética , Orina/química , Anticarcinógenos/sangre , Anticarcinógenos/farmacocinética , Anticarcinógenos/orina , Brassica/química , Cromatografía Líquida de Alta Presión , Pruebas de Química Clínica/métodos , Pruebas de Química Clínica/normas , Humanos , Indicadores y Reactivos , Isotiocianatos/sangre , Isotiocianatos/farmacocinética , Isotiocianatos/orina , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Extractos Vegetales/farmacocinética , Sensibilidad y Especificidad , Compuestos de Sulfhidrilo , Tiocarbamatos/sangre , Tiocarbamatos/orina , TionasRESUMEN
OBJECTIVE: The biological properties of a new neutral myocardial imaging agent 99mTcN(NOEt)2 were evaluated. METHODS: Blood clearance in rabbits, biodistribution in rats, and initial myocardial imaging in dogs were performed. RESULTS: Radiochemical purity of 99mTcN(NOEt)2 was more than 90% and stable for 6 h at room temperature. Blood disappearance was analyzed with a biexponential model and T1/2(alpha) = 2.53 min, T1/2(beta) = 330 min and CI = 378 ml/h were obtained. Biodistribution studies demonstrated that 99mTcN(NOEt)2 localized selectively in the rat myocardium. Cardiac uptakes were 4.69, 4.20, 3.95 and 3.43% ID/g at 5, 30, 60 and 90 min postinjection, respectively. The mean heart-to-lung activity ratios were 1.69, 2.40 and 2.55 at 10 min, 30 min and 60 min postinjection, respectively. CONCLUSION: Technetium-99m-N(NOEt)2 exhibited favorable stability and biological properties. Further study in humans is required.
Asunto(s)
Corazón/diagnóstico por imagen , Compuestos de Organotecnecio/farmacocinética , Tiocarbamatos/farmacocinética , Animales , Perros , Estabilidad de Medicamentos , Compuestos de Organotecnecio/sangre , Conejos , Cintigrafía , Radiofármacos/sangre , Radiofármacos/farmacocinética , Ratas , Temperatura , Tiocarbamatos/sangreRESUMEN
BACKGROUND: 99mTc-N-NOET (NOET) is a new myocardial perfusion imaging agent that redistributes over time. We sought to better define the redistribution kinetics of NOET using open-chest canine models of sustained low coronary flow (protocol 1) and transient coronary occlusion followed by reflow (protocol 2). METHODS AND RESULTS: In protocol 1 (n=10), NOET and 201Tl were injected during low flow in the left anterior descending coronary artery (LAD) that was sustained for 2 hours. Protocol 2 dogs (n=6) were injected with NOET during 20 minutes of LAD occlusion followed by 2 hours of reflow. In both protocols, serial NOET planar images were acquired, and myocardial flow and 2-hour tracer activities were determined by gamma-well counting. Defect resolution was observed on images in both protocols. Initial defect count ratios, reflecting flow disparity at injection (0.66+/-0.03 and 0.57+/-0.04, respectively), increased over 2 hours (0.73+/-0.02 and 0.75+/-0.04, respectively; P<.001 versus initial). Quantitative imaging showed that NOET redistribution resulted from greater clearance from normal areas versus low-flow or transiently occluded areas. In protocol 1, 2-hour NOET and 201Tl stenotic-to-normal tissue activity ratios were similar (0.76+/-0.06 versus 0.73+/-0.04, P=NS) and higher than injection flow ratios (0.52+/-0.06 and 0.56+/-0.07, respectively, P<.001), consistent with tracer redistribution. In protocol 2, NOET redistributed to an even greater extent (injection flow ratio, 0.27+/-0.04; 2-hour tissue activity ratio, 0.84+/-0.03, P<.001). CONCLUSIONS: NOET is the first 99mTc-labeled myocardial imaging agent with kinetics similar to 201Tl in experimental models, permitting redistribution imaging. NOET appears to be a promising agent for assessing patients with coronary artery disease.
Asunto(s)
Circulación Coronaria/fisiología , Enfermedad Coronaria/fisiopatología , Vasos Coronarios/fisiopatología , Corazón/diagnóstico por imagen , Hemodinámica , Miocardio/metabolismo , Compuestos de Organotecnecio/farmacocinética , Radiofármacos/farmacocinética , Talio/farmacocinética , Tiocarbamatos/farmacocinética , Animales , Presión Sanguínea , Enfermedad Coronaria/diagnóstico por imagen , Vasos Coronarios/fisiología , Perros , Frecuencia Cardíaca , Masculino , Microesferas , Compuestos de Organotecnecio/sangre , Cintigrafía , Flujo Sanguíneo Regional , Talio/sangre , Tiocarbamatos/sangre , Distribución Tisular , Función Ventricular IzquierdaRESUMEN
In this study, we have investigated the preparation of rhenium-188 nitridobis(N-ethoxy-N-ethyldithiocarbamate) [188ReN(NOET)2] (NOET = Et(EtO)NCS2), analogous to the known technetium-99m radiopharmaceutical. The new 188Re complex was synthesized in good yield with a satisfactory radiochemical purity, using a kit method. The subcellular localization of both radiopharmaceuticals in granulocytes was observed by microautoradiography. The uptake was independent of the radionuclide and predominantly nuclear. Furthermore, HPLC was used to characterize the 99mTc complex before and after blood cell labelling and revealed that the intact radiopharmaceutical was involved.
Asunto(s)
Compuestos Organometálicos/sangre , Compuestos Organometálicos/síntesis química , Compuestos de Organotecnecio/sangre , Compuestos de Organotecnecio/síntesis química , Radiofármacos/sangre , Radiofármacos/síntesis química , Renio , Tecnecio , Tiocarbamatos/sangre , Tiocarbamatos/síntesis química , Autorradiografía , Células Cultivadas , Cromatografía Líquida de Alta Presión , Humanos , Compuestos Organometálicos/farmacocinética , Compuestos de Organotecnecio/farmacocinética , Radioisótopos/química , Radiofármacos/farmacocinética , Renio/química , Fracciones Subcelulares/metabolismo , Tecnecio/química , Tiocarbamatos/farmacocinéticaRESUMEN
The effects of N-benzyl-D-glucamine dithiocarbamate (BGD), diethyldithiocarbamate (DDTC), and N-p-hydroxymethylbenzyl-D-glucamine dithiocarbamate (HBGD) on the enzymatic activities in mice were studied. The mice were given i.v. injections of these chelating agents (1 mmol/kg) and 3 h later the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltranspeptidase (gamma-GTP), alkaline phosphatase (ALP), leucine aminopeptidase (LAP), and cholinesterase (ChE) in the liver, kidney, and blood were determined. These enzymatic activities were little changed by treatment with these chelating agents. Cadmium (Cd) administration markedly decreased the activities of AST and ALT in the liver and kidney and greatly increased these enzymatic activities in blood. The changes in the enzymatic activities by treatment with Cd were prevented by injection of BGD (1 mmol/kg). These results indicate that BGD, DDTC, and HBGD were not toxic to the liver or kidney of mice and that BGD treatment protected against the acute hepatic and renal toxicity induced by Cd.
Asunto(s)
Cadmio/toxicidad , Quelantes/toxicidad , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Tiocarbamatos/toxicidad , Alanina Transaminasa/sangre , Alanina Transaminasa/metabolismo , Fosfatasa Alcalina/sangre , Fosfatasa Alcalina/metabolismo , Análisis de Varianza , Animales , Aspartato Aminotransferasas/sangre , Aspartato Aminotransferasas/metabolismo , Cadmio/administración & dosificación , Cadmio/sangre , Colinesterasas/sangre , Colinesterasas/metabolismo , Ditiocarba/administración & dosificación , Ditiocarba/metabolismo , Ditiocarba/farmacología , Inyecciones Intravenosas , Riñón/enzimología , Leucil Aminopeptidasa/sangre , Leucil Aminopeptidasa/metabolismo , Hígado/enzimología , Masculino , Ratones , Estándares de Referencia , Sorbitol/administración & dosificación , Sorbitol/análogos & derivados , Sorbitol/sangre , Sorbitol/toxicidad , Tiocarbamatos/administración & dosificación , Tiocarbamatos/sangre , gamma-Glutamiltransferasa/sangre , gamma-Glutamiltransferasa/metabolismoRESUMEN
A method was developed for the assay of benzoic acid, 2-chloro-5-[[(1-methylethoxyl)thioxomethyl]amino]-,1-meth yle thyl ester (NSC 629243) in hamster, mouse, human and, to a limited extent, dog plasma. Protein in 0.5 ml of plasma was precipitated with four volumes of methanol and the supernatant was analysed for NSC 629243 by LC. Liquid chromatography was carried out on a reversed-phase Nova-Pak C18 column, with a mobile phase of 60% acetonitrile in water at 1 ml min-1, and the compound was quantified with a UV detector set at 283 nm. Two standard curves of NSC 629243 were needed to cover a concentration range of 0.05-100 micrograms ml-1. All standard curves had correlation coefficients > 0.999. In practice, the minimum quantifiable concentration was approximately 0.05 microgram ml-1 in 0.5 ml of plasma. NSC 629243 appeared to have good stability at 37 degrees C in hamster, human and dog plasma at concentrations of 1 and 50 micrograms ml-1 (at least 80% remained in plasma after a 4 h incubation). Breakdown occurred in mouse plasma after 1 h at 37 degrees C, with extensive breakdown occurring after 24 h. NSC 629243 was extensively bound to plasma proteins of Syrian hamsters and humans. The extent of binding ranged from a minimum of 88.6% to a maximum of 99.9% over a concentration range of ca 1-100 micrograms ml-1.
Asunto(s)
Antivirales/sangre , Benzoatos/sangre , Proteínas Sanguíneas/metabolismo , Tiocarbamatos/sangre , Animales , Antivirales/metabolismo , Benzoatos/metabolismo , Cromatografía Líquida de Alta Presión , Cricetinae , Perros , Estabilidad de Medicamentos , VIH/efectos de los fármacos , Humanos , Masculino , Mesocricetus , Ratones , Unión Proteica , Estándares de Referencia , Solubilidad , Espectrofotometría Ultravioleta , Tiocarbamatos/metabolismoRESUMEN
Rats were treated with disulfiram (Antabuse, DSF) or its metabolite diethyldithiocarbamic acid methyl ester (Me-DDC) and challenged with ethanol. The blood pressure response to ethanol was followed and blood was analyzed for DSF, Me-DDC and diethyldithiocarbamic acid (DDC). The rat liver aldehyde dehydrogenase (ALDH) isozyme activities were measured 2 hr after the ethanol challenge. Both treatments produced a significant fall in the blood pressure when challenged with ethanol, probably caused by a marked decrease in hepatocyte low Km and high Km activities. The mean plasma concentration ranges of Me-DDC and DDC were found to be 49-1241 nmol/l and 182-841 nmol/l, respectively, whereas DSF was undetectable. In addition, it was found that inactivation of hepatocyte low Km ALDH activity was dependent on preoxidation of Me-DDC by the microsomal cytochrome P-450 mixed function oxidases. Me-DDC was found to be oxidized under aerobic conditions in the presence of NADP to form diethylthiocarbamic acid methyl ester (Me-DTC). The structure was confirmed from its MS/EI fragmentation spectrum. Me-DTC was found to be a potent inhibitor of low Km ALDH when added to rat liver homogenate. The compound was also identified as a metabolite in rat blood collected from the DSF and Me-DDC treated rats, and in blood from human alcoholics on DSF treatment. Me-DTC appears to be more selective for the low Km isozymes whereas the opposite seems to be the case for the hydrolytic product, DTC.
Asunto(s)
Aldehído Deshidrogenasa/antagonistas & inhibidores , Disulfiram/farmacología , Ditiocarba/análogos & derivados , Tiocarbamatos/biosíntesis , Animales , Presión Sanguínea/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/metabolismo , Disulfiram/sangre , Disulfiram/metabolismo , Ditiocarba/sangre , Ditiocarba/metabolismo , Ditiocarba/farmacología , Etanol/sangre , Etanol/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Oxigenasas de Función Mixta/metabolismo , Ratas , Ratas Endogámicas , Tiocarbamatos/sangre , Tiocarbamatos/farmacologíaRESUMEN
Three contaminants were identified during drug screening of postmortem blood samples which had been stored in glass bottles with a black rubber seal. Two of these contaminants, cyanoethyl dimethyldithiocarbamate and N-phenyl-2-naphthylamine, were found to come from the rubber seal of some bottles. The third contaminant was not a single compound but rather a mixture of aryl phosphates with a composition very similar to technical grade tritolyl phosphate. The origin of these phosphates is at present unknown.
Asunto(s)
2-Naftilamina/sangre , Recolección de Muestras de Sangre/instrumentación , Cresoles/sangre , Naftalenos/sangre , Goma , Tiocarbamatos/sangre , Tritolilfosfatos/sangre , 2-Naftilamina/análogos & derivados , Cromatografía de Gases y Espectrometría de Masas , HumanosRESUMEN
Niridazole and six of its metabolites have been quantitated by high-pressure liquid chromatography in sera of four male Filipino patients with mild Schistosoma japonicum infections given single oral doses of niridazole (15 mg/kg) on two occasions 10 days apart. Of the five oxidative metabolites measured, 4-hydroxyniridazole and 4-ketoniridazole achieved the highest concentrations, reaching peak values of 0.9 +/- 0.3 microgram/ml of serum (mean +/- S.D., n = 4) and 0.7 +/- 0.1 microgram/ml of serum within 1 to 4 hr. 4-Ketoniridazole achieved peak serum levels 1 hr after the other oxidative metabolites in three of four patients and was the predominant metabolite in the serum of all patients 6 to 10 hr after dosing. By 24 hr, both 4-ketoniridazole and 4-hydroxyniridazole had largely disappeared from the serum. Niridazole and three other oxidative metabolites, 4,5-dihydroxyniridazole, 5-hydroxyniridazole and 4,5-dehydroniridazole, appeared within 1 hr in serum but failed to exceed 0.4 microgram/ml; none of these compounds were detected in the 24-hr serum samples. The pharmacokinetic pattern of niridazole and the oxidative metabolites showed marked interindividual variation but was quite reproducible in the same individual studied 10 days later. 1-Thiocarbamoyl-2-imidazolidinone was analyzed in serum samples by a different high-pressure liquid chromatographic procedure. This reductive metabolite attained maximal levels of 50 to 150 ng/ml of serum 6 to 12 hr after drug administration and remained at 40% or more of its peak concentration even after 24 hr.(ABSTRACT TRUNCATED AT 250 WORDS)